Inflammatory response and oxidative stress attenuated by sulfiredoxin‑1 in neuron‑like cells depends on nuclear factor erythroid‑2‑related factor 2

Wu,Zhiliang; Lu,Zhenghao; Ou,Jun; Su,Xiaotao; Liu,Jingnan

doi:10.3892/mmr.2020.11545

Inflammatory response and oxidative stress attenuated by sulfiredoxin‑1 in neuron‑like cells depends on nuclear factor erythroid‑2‑related factor 2

Authors:
- Zhiliang Wu
- Zhenghao Lu
- Jun Ou
- Xiaotao Su
- Jingnan Liu
View Affiliations

Affiliations: Department of Spinal Surgery, Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan 421000, P.R. China
Published online on: September 28, 2020 https://doi.org/10.3892/mmr.2020.11545
Pages: 4734-4742
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sulfiredoxin‑1 (SRX1) is a conserved endogenous antioxidative protein, which is involved in the response to cellular damage caused by oxidative stress. Oxidative stress and inflammation are the primary pathological changes in spinal cord injuries (SCI). The aim of present study was to explore the roles of SRX1 in SCI. Using reverse transcription‑quantitative PCR and western blotting, the present study discovered that the expression levels of SRX1 were downregulated in the spinal cord tissues of SCI model rats. Massive irregular cavities and decreased Nissl bodies were observed in the model group compared with the sham group. Thus, to determine the underlying mechanisms, neuron‑like PC12 cells were cultured in vitro. Western blotting analysis indicated that SRX1 expression levels were downregulated following the exposure of cells to lipopolysaccharide (LPS). Following the transfection with the SRX1 overexpression plasmid and stimulation with LPS, the results of the Cell Counting Kit‑8 assay indicated that the cell viability was increased compared with LPS stimulation alone. Furthermore, the expression levels of proinflammatory cytokines secreted by LPS‑treated PC12 cells were downregulated following SRX1 overexpression. Increased malondialdehyde content, decreased superoxide dismutase activity and reactive oxygen species production were also identified in PC12 cells treated with LPS using commercial detection kits, whereas the overexpression of SRX1 partially reversed the effects caused by LPS stimulation. The aforementioned results were further verified by determining the expression levels of antioxidative proteins using western blotting analysis. In addition, nuclear factor erythroid‑2‑related factor 2 (NRF2), a transcription factor known to regulate SRX1, was indicated to participate in the protective effect of SRX1 against oxidative stress. Inhibition of NRF2 further downregulated the expression levels of SRX1, NAD(P)H dehydrogenase quinone 1 and heme oxygenase‑1 in the presence of LPS, while activation of NRF2 reversed the effects of LPS on the expression levels of these proteins. In conclusion, the results of the present study indicated that the anti‑inflammatory and antioxidative effects of SRX1 may depend on NRF2, providing evidence that SRX1 may serve as a novel molecular target to exert a neuroprotective effect in SCI.

View Figures

View References

1	Fakhoury M: Spinal cord injury: Overview of experimental approaches used to restore locomotor activity. Rev Neurosci. 26:397–405. 2015. View Article : Google Scholar : PubMed/NCBI
2	Scivoletto G, Miscusi M, Forcato S, Ricciardi L, Serrao M, Bellitti R and Raco A: The rehabilitation of spinal cord injury patients in Europe. Acta Neurochir Suppl. 124:203–210. 2017. View Article : Google Scholar : PubMed/NCBI
3	Friedli L, Rosenzweig ES, Barraud Q, Schubert M, Dominici N, Awai L, Nielson JL, Musienko P, Nout-Lomas Y, Zhong H, et al: Pronounced species divergence in corticospinal tract reorganization and functional recovery after lateralized spinal cord injury favors primates. Sci Transl Med. 7:302ra1342015. View Article : Google Scholar : PubMed/NCBI
4	Cramer SC, Lastra L, Lacourse MG and Cohen MJ: Brain motor system function after chronic, complete spinal cord injury. Brain. 128:2941–2950. 2005. View Article : Google Scholar : PubMed/NCBI
5	Sekhon LH and Fehlings MG: Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976). 26 (Suppl 24):S2–S12. 2001. View Article : Google Scholar : PubMed/NCBI
6	Beattie MS: Inflammation and apoptosis: Linked therapeutic targets in spinal cord injury. Trends Mol Med. 10:580–583. 2004. View Article : Google Scholar : PubMed/NCBI
7	Lin XY, Lai BQ, Zeng X, Che MT, Ling EA, Wu W and Zeng YS: Cell Transplantation and neuroengineering approach for spinal cord injury treatment: A summary of current laboratory findings and review of literature. Cell Transplant. 25:1425–1438. 2016. View Article : Google Scholar : PubMed/NCBI
8	Ordikhani F, Sheth S and Zustiak SP: Polymeric particle-mediated molecular therapies to treat spinal cord injury. Int J Pharm. 516:71–81. 2017. View Article : Google Scholar : PubMed/NCBI
9	Silva NA, Sousa N, Reis RL and Salgado AJ: From basics to clinical: A comprehensive review on spinal cord injury. Prog Neurobiol. 114:25–57. 2014. View Article : Google Scholar : PubMed/NCBI
10	Chen S, Ye J, Chen X, Shi J, Wu W, Lin W, Lin W, Li Y, Fu H and Li S: Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3. J Neuroinflammation. 15:1502018. View Article : Google Scholar : PubMed/NCBI
11	Lin X, Zhu J, Ni H, Rui Q, Sha W, Yang H, Li D and Chen G: Treatment with 2-BFI attenuated spinal cord injury by inhibiting oxidative stress and neuronal apoptosis via the Nrf2 signaling pathway. Front Cell Neurosci. 13:5672019. View Article : Google Scholar : PubMed/NCBI
12	Ying X, Tu W, Li S, Wu Q, Chen X, Zhou Y, Hu J, Yang G and Jiang S: Hyperbaric oxygen therapy reduces apoptosis and dendritic/synaptic degeneration via the BDNF/TrkB signaling pathways in SCI rats. Life Sci. 229:187–199. 2019. View Article : Google Scholar : PubMed/NCBI
13	Zanuzzi CN, Nishida F, Sisti MS, Barbeito CG and Portiansky EL: Reactivity of microglia and astrocytes after an excitotoxic injury induced by kainic acid in the rat spinal cord. Tissue Cell. 56:31–40. 2019. View Article : Google Scholar : PubMed/NCBI
14	Findlay VJ, Tapiero H and Townsend DM: Sulfiredoxin: A potential therapeutic agent? Biomed Pharmacother. 59:374–379. 2005. View Article : Google Scholar : PubMed/NCBI
15	Singh A, Ling G, Suhasini AN, Zhang P, Yamamoto M, Navas-Acien A, Cosgrove G, Tuder RM, Kensler TW, Watson WH and Biswal S: Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med. 46:376–386. 2009. View Article : Google Scholar : PubMed/NCBI
16	Biteau B, Labarre J and Toledano MB: ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature. 425:980–984. 2003. View Article : Google Scholar : PubMed/NCBI
17	Li Q, Yu S, Wu J, Zou Y and Zhao Y: Sulfiredoxin-1 protects PC12 cells against oxidative stress induced by hydrogen peroxide. J Neurosci Res. 91:861–870. 2013. View Article : Google Scholar : PubMed/NCBI
18	Li X, He P, Wang XL, Zhang S, Devejian N, Bennett E and Cai C: Sulfiredoxin-1 enhances cardiac progenitor cell survival against oxidative stress via the upregulation of the ERK/NRF2 signal pathway. Free Radic Biol Med. 123:8–19. 2018. View Article : Google Scholar : PubMed/NCBI
19	Zhang J, He Z, Guo J, Li Z, Wang X, Yang C and Cui X: Sulfiredoxin-1 protects against simulated ischaemia/reperfusion injury in cardiomyocyte by inhibiting PI3K/AKT-regulated mitochondrial apoptotic pathways. Biosci Rep. 36:e003252016. View Article : Google Scholar : PubMed/NCBI
20	Soubeyrand M, Badner A, Vawda R, Chung YS and Fehlings MG: Very high resolution ultrasound imaging for real-time quantitative visualization of vascular disruption after spinal cord injury. J Neurotrauma. 31:1767–1775. 2014. View Article : Google Scholar : PubMed/NCBI
21	Can H, Aydoseli A, Gömleksiz C, Göker B, Altunrende ME, Dolgun M and Sencer A: Combined and individual use of pancaspase inhibitor Q-VD-OPh and NMDA receptor antagonist riluzole in experimental spinal cord injury. Ulus Travma Acil Cerrahi Derg. 23:452–458. 2017.PubMed/NCBI
22	Goldshmit Y, Tang J, Siegel AL, Nguyen PD, Kaslin J, Currie PD and Jusuf PR: Different Fgfs have distinct roles in regulating neurogenesis after spinal cord injury in zebrafish. Neural Dev. 13:242018. View Article : Google Scholar : PubMed/NCBI
23	Zhong ZX, Feng SS, Chen SZ, Chen ZM and Chen XW: Inhibition of MSK1 promotes inflammation and apoptosis and inhibits functional recovery after spinal cord injury. J Mol Neurosci. 68:191–203. 2019. View Article : Google Scholar : PubMed/NCBI
24	Shen LM, Song ZW, Hua Y, Chao X and Liu JB: miR-181d-5p promotes neurite outgrowth in PC12 Cells via PI3K/Akt pathway. CNS Neurosci Ther. 23:894–906. 2017. View Article : Google Scholar : PubMed/NCBI
25	Martin TF and Grishanin RN: PC12 cells as a model for studies of regulated secretion in neuronal and endocrine cells. Methods Cell Biol. 71:267–286. 2003. View Article : Google Scholar : PubMed/NCBI
26	Khodagholi F and Tusi SK: Stabilization of Nrf2 by tBHQ prevents LPS-induced apoptosis in differentiated PC12 cells. Mol Cell Biochem. 354:97–112. 2011. View Article : Google Scholar : PubMed/NCBI
27	Gallorini M, Petzel C, Bolay C, Hiller KA, Cataldi A, Buchalla W, Krifka S and Schweikl H: Activation of the Nrf2-regulated antioxidant cell response inhibits HEMA-induced oxidative stress and supports cell viability. Biomaterials. 56:114–128. 2015. View Article : Google Scholar : PubMed/NCBI
28	Singh A, Venkannagari S, Oh KH, Zhang YQ, Rohde JM, Liu L, Nimmagadda S, Sudini K, Brimacombe KR, Gajghate S, et al: Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors. ACS Chem Biol. 11:3214–3225. 2016. View Article : Google Scholar : PubMed/NCBI
29	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
30	Mittal M, Siddiqui MR, Tran K, Reddy SP and Malik AB: Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 20:1126–1167. 2014. View Article : Google Scholar : PubMed/NCBI
31	Wu J, Chen Y, Yu S, Li L, Zhao X, Li Q, Zhao J and Zhao Y: Neuroprotective effects of sulfiredoxin-1 during cerebral ischemia/reperfusion oxidative stress injury in rats. Brain Res Bull. 132:99–108. 2017. View Article : Google Scholar : PubMed/NCBI
32	Li X, Zhan J, Hou Y, Hou Y, Chen S, Luo D, Luan J, Wang L and Lin D: Coenzyme Q10 regulation of apoptosis and oxidative stress in H₂O₂ Induced BMSC death by modulating the Nrf-2/NQO-1 signaling pathway and its application in a model of spinal cord injury. Oxid Med Cell Longev. 2019:64930812019. View Article : Google Scholar : PubMed/NCBI
33	Hachem LD, Ahuja CS and Fehlings MG: Assessment and management of acute spinal cord injury: From point of injury to rehabilitation. J Spinal Cord Med. 40:665–675. 2017. View Article : Google Scholar : PubMed/NCBI
34	Zhou Y, Zhou Y, Yu S, Wu J, Chen Y and Zhao Y: Sulfiredoxin-1 exerts anti-apoptotic and neuroprotective effects against oxidative stress-induced injury in rat cortical astrocytes following exposure to oxygen-glucose deprivation and hydrogen peroxide. Int J Mol Med. 36:43–52. 2015. View Article : Google Scholar : PubMed/NCBI
35	Lee JY, Joo B, Nam JH, Nam HY, Lee W, Nam Y, Seo Y, Kang HJ, Cho HJ, Jang YP, et al: An aqueous extract of herbal medicine ALWPs enhances cognitive performance and inhibits LPS-induced neuroinflammation via FAK/NF-κb signaling pathways. Front Aging Neurosci. 10:2692018. View Article : Google Scholar : PubMed/NCBI
36	Shah SA, Khan M, Jo MH, Jo MG, Amin FU and Kim MO: Melatonin stimulates the SIRT1/Nrf2 signaling pathway counteracting lipopolysaccharide (LPS)-induced oxidative stress to rescue postnatal rat brain. CNS Neurosci Ther. 23:33–44. 2017. View Article : Google Scholar : PubMed/NCBI
37	Ashtekar A, Huk D, Magner A, La Perle KMD, Boucai L and Kirschner LS: Alterations in Sod2-induced oxidative stress affect endocrine cancer progression. J Clin Endocrinol Metab. 103:4135–4145. 2018. View Article : Google Scholar : PubMed/NCBI
38	Kubo E, Chhunchha B, Singh P, Sasaki H and Singh DP: Sulforaphane reactivates cellular antioxidant defense by inducing Nrf2/ARE/Prdx6 activity during aging and oxidative stress. Sci Rep. 7:141302017. View Article : Google Scholar : PubMed/NCBI
39	Ding C, Fan X and Wu G: Peroxiredoxin 1-an antioxidant enzyme in cancer. J Cell Mol Med. 21:193–202. 2017. View Article : Google Scholar : PubMed/NCBI
40	Tuo L, Xiang J, Pan X, Gao Q, Zhang G, Yang Y, Liang L, Xia J, Wang K and Tang N: PCK1 downregulation promotes TXNRD1 expression and hepatoma cell growth via the Nrf2/Keap1 pathway. Front Oncol. 8:6112018. View Article : Google Scholar : PubMed/NCBI
41	Wu S, Lu H and Bai Y: Nrf2 in cancers: A double-edged sword. Cancer Med. 8:2252–2267. 2019. View Article : Google Scholar : PubMed/NCBI
42	Magesh S, Chen Y and Hu L: Small molecule modulators of Keap1-Nrf2-are pathway as potential preventive and therapeutic agents. Med Res Rev. 32:687–726. 2012. View Article : Google Scholar : PubMed/NCBI
43	Lin CW, Chen B, Huang KL, Dai YS and Teng HL: Inhibition of autophagy by estradiol promotes locomotor recovery after spinal cord injury in rats. Neurosci Bull. 32:137–144. 2016. View Article : Google Scholar : PubMed/NCBI
44	He Z, Zhou Y, Huang Y, Wang Q, Zheng B, Zhang H, Li J, Liu Y, Wu F, Zhang X, et al: Dl-3-n-butylphthalide improves functional recovery in rats with spinal cord injury by inhibiting endoplasmic reticulum stress-induced apoptosis. Am J Transl Res. 9:1075–1087. 2017.PubMed/NCBI